176 related articles for article (PubMed ID: 20008773)
1. Murine model of a disseminated infection by the novel fungus Fonsecaea monophora and successful treatment with posaconazole.
Calvo E; Pastor FJ; Rodríguez MM; Mayayo E; Salas V; Guarro J
Antimicrob Agents Chemother; 2010 Feb; 54(2):919-23. PubMed ID: 20008773
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Posaconazole in a Murine Model of Systemic Infection by Saprochaete capitata.
Thomson P; Guarro J; Mayayo E; Capilla J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7477-82. PubMed ID: 26392490
[TBL] [Abstract][Full Text] [Related]
3. Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.
Rodríguez MM; Pastor FJ; Calvo E; Salas V; Sutton DA; Guarro J
Antimicrob Agents Chemother; 2009 Dec; 53(12):5022-5. PubMed ID: 19786601
[TBL] [Abstract][Full Text] [Related]
4. Posaconazole efficacy in a murine disseminated infection caused by Paecilomyces lilacinus.
Rodríguez MM; Pastor FJ; Serena C; Guarro J
J Antimicrob Chemother; 2009 Feb; 63(2):361-4. PubMed ID: 19054804
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of caspofungin and posaconazole in a murine model of disseminated Exophiala infection.
Rivard RG; McCall S; Griffith ME; Hawley JS; Ressner RA; Borra H; Moon JE; Beckius ML; Murray CK; Hospenthal DR
Med Mycol; 2007 Dec; 45(8):685-9. PubMed ID: 17885951
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection.
Ruíz-Cendoya M; Madrid H; Pastor J; Guarro J
Int J Antimicrob Agents; 2010 Feb; 35(2):152-5. PubMed ID: 20005680
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense.
Fernández-Silva F; Capilla J; Mayayo E; Sutton DA; Hernández P; Guarro J
Antimicrob Agents Chemother; 2013 Dec; 57(12):6265-9. PubMed ID: 24100490
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani.
Wiederhold NP; Najvar LK; Bocanegra R; Graybill JR; Patterson TF
Antimicrob Agents Chemother; 2010 Mar; 54(3):1055-9. PubMed ID: 20065054
[TBL] [Abstract][Full Text] [Related]
9. Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.
Groll AH; Walsh TJ
Mycoses; 2006; 49 Suppl 1():7-16. PubMed ID: 16961576
[TBL] [Abstract][Full Text] [Related]
10. Experimental treatment of Curvularia infection.
Paredes K; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Guarro J
Diagn Microbiol Infect Dis; 2014 Aug; 79(4):428-31. PubMed ID: 24938759
[TBL] [Abstract][Full Text] [Related]
11. Posaconazole therapy of disseminated phaeohyphomycosis in a murine model.
Graybill JR; Najvar LK; Johnson E; Bocanegra R; Loebenberg D
Antimicrob Agents Chemother; 2004 Jun; 48(6):2288-91. PubMed ID: 15155236
[TBL] [Abstract][Full Text] [Related]
12. Activity of posaconazole in treatment of experimental disseminated zygomycosis.
Dannaoui E; Meis JF; Loebenberg D; Verweij PE
Antimicrob Agents Chemother; 2003 Nov; 47(11):3647-50. PubMed ID: 14576138
[TBL] [Abstract][Full Text] [Related]
13. Posaconazole: a new broad-spectrum antifungal agent.
Kwon DS; Mylonakis E
Expert Opin Pharmacother; 2007 Jun; 8(8):1167-78. PubMed ID: 17516880
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole.
Salas V; Pastor FJ; Calvo E; Alvarez E; Sutton DA; Mayayo E; Fothergill AW; Rinaldi MG; Guarro J
Antimicrob Agents Chemother; 2012 May; 56(5):2246-50. PubMed ID: 22290952
[TBL] [Abstract][Full Text] [Related]
15. Molecular Identification of Fonsecaea monophora, Novel Agent of Fungal Brain Abscess.
Gourav S; Singh G; Pandey M; Rana B; Gupta S; Mishra H; Xess I
Emerg Infect Dis; 2024 Jun; 30(6):1232-1235. PubMed ID: 38782016
[TBL] [Abstract][Full Text] [Related]
16. SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum ("Ramichloridium mackenziei").
Al-Abdely HM; Najvar L; Bocanegra R; Fothergill A; Loebenberg D; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 2000 May; 44(5):1159-62. PubMed ID: 10770745
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
Najafzadeh MJ; Badali H; Illnait-Zaragozi MT; De Hoog GS; Meis JF
Antimicrob Agents Chemother; 2010 Apr; 54(4):1636-8. PubMed ID: 20086140
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of posaconazole in a murine model of disseminated trichosporonosis.
Treviño-Rangel Rde J; López LJ; Palma-Nicolás JP; Hernández-Bello R; González JG; González GM
J Antimicrob Chemother; 2014 Apr; 69(4):1075-8. PubMed ID: 24252752
[TBL] [Abstract][Full Text] [Related]
19. Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana.
Mariné M; Pastor FJ; Guarro J
Med Mycol; 2009 Feb; 47(1):45-9. PubMed ID: 19085457
[TBL] [Abstract][Full Text] [Related]
20. Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole.
Al-Abdely HM; Alkhunaizi AM; Al-Tawfiq JA; Hassounah M; Rinaldi MG; Sutton DA
Med Mycol; 2005 Feb; 43(1):91-5. PubMed ID: 15712614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
